These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 1683609

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The potential beneficial effects of beta adrenergic blockade in the treatment of ventricular fibrillation.
    Bassiakou E, Xanthos T, Papadimitriou L.
    Eur J Pharmacol; 2009 Aug 15; 616(1-3):1-6. PubMed ID: 19555681
    [Abstract] [Full Text] [Related]

  • 7. Role of angiotensin II in sympathetic nervous system induced left ventricular dysfunction.
    Bosso FJ, Jarjoura DG, Pilati CF.
    Can J Physiol Pharmacol; 1999 Oct 15; 77(10):806-12. PubMed ID: 10588485
    [Abstract] [Full Text] [Related]

  • 8. Fibrinogen and plasminogen activator inhibitor-1 levels in hypertension and coronary heart disease. Potential effects of beta-blockade.
    Teger-Nilsson AC, Larsson PT, Hjemdahl P, Olsson G.
    Circulation; 1991 Dec 15; 84(6 Suppl):VI72-7. PubMed ID: 1683612
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
    Man in't Veld AJ, Schalekamp MA.
    Postgrad Med J; 1983 Dec 15; 59 Suppl 3(689):140-58. PubMed ID: 6139800
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Hypertension and new antihypertensive drugs: clinical perspectives.
    Dollery CT.
    Fed Proc; 1983 Feb 15; 42(2):207-10. PubMed ID: 6295822
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The response of plasma catecholamines to the vasodepression caused by beta-adrenoceptor antagonists in the spontaneously hypertensive rat.
    Keeton TK.
    J Hypertens Suppl; 1986 Oct 15; 4(3):S197-9. PubMed ID: 2878069
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Exercise tolerance and compensatory sympathetic tone during beta-blockade after myocardial infarction.
    Brice G, Stone HL.
    Med Sci Sports Exerc; 1986 Aug 15; 18(4):396-401. PubMed ID: 2875377
    [Abstract] [Full Text] [Related]

  • 20. Cardiac actions of central but not peripheral urotensin II are prevented by beta-adrenoceptor blockade.
    Hood SG, Watson AM, May CN.
    Peptides; 2005 Jul 15; 26(7):1248-56. PubMed ID: 15949643
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.